Promising Drug Offers Prostate Cancer Hope

A new study offers rare hope to men with advanced prostate cancer. According to phase-I clinical results published in the Journal of Clinical Oncology on Tuesday, a new drug, abiraterone, dramatically shrunk the size of tumors and offered lasting benefits for prostate patients, compared with existing treatments. This year, according to the American Cancer Society, an estimated 186,000 men in the U.S. will be diagnosed with prostate cancer, and about 28,000 will die from the disease. ...Full Story
Commenting on this article is closed.